Vitamin E overlooked by 90% of the nation

New Delhi, 18 October, 2018: Merck Consumer Health India – a leader in Vitamin E in India – announced the publication of the country’s first handbook that highlights the hitherto unknown benefits and widespread utility of Vitamin E titled –“Vitamin E: Clinical Applications and Evidences”. This book has been edited by Dr. YK Gupta and Dr. AC Anand, leading health practitioners and experts in their fields, and is an amalgamation of the manifold uses of Vitamin E as a supplement. Along with the book launch, a panel of expert doctors from different specialties have contributed to the positive role of Vitamin E in various health issues.

Despite an increase in awareness of the role of various Vitamins, only 9% of India is aware of the role of Vitamin E. While most individuals resort to Vitamin E for common ailments, the true potential of this nutraceutical still witnesses a lack of awareness on a large scale. The purpose of this book is to highlight the fact that Vitamin E also offers protection against an extensive list of lifestyle-induced issues; issues that are usually not under the spotlight.

Commenting on this launch, MD of Merck India, Milind Thatte said, “Merck is proud to launch this all-inclusive book on Vitamin E, in partnership with leading doctors and Springer publications. People in our country are not entirely aware of the extensive benefits offered by Vitamin E. Authored by industry experts who have factored the insights of top Indian doctors, this book is our endeavor to increase the awareness about the benefits of Vitamin E backed scientific data and clinical evidence.”

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre